publicações selecionadas
-
artigo académico
- Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma. Molecular Oncology. 2022
- Chronic Stress Does Not Influence the Survival of Mouse Models of Glioblastoma. Frontiers in Oncology. 2022
-
artigo de revista
- WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma. Theranostics. 2018
- The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma. Oncotarget. 2018
- Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis. Journal of Neuro-Oncology. 2017
- Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas. Oncotarget. 2016
- Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models. Genomics Data. 2015
- A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide. Oncotarget. 2015
- A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide. Oncotarget. 2015
- In vitro evaluation of the cytotoxicity and cellular uptake of CMCht/PAMAM dendrimer nanoparticles by glioblastoma cell models. Journal of Nanoparticle Research. 2013
-
capítulo de livro
-
documento
- CDH3/P-cadherin is a novel oncogenic biomarker with prognostic value in glioblastoma 2020
- Deciphering WNT6 up and down roads in glioblastoma: mechanistic, functional, and clinical insight 2020
- Functional and prognostic relevance of CDH3/P-cadherin in glioblastoma 2019
- WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma 2019
- Deciphering key roles of WNT6 in glioblastoma: mechanistic, functional, and clinical insights 2019
- CDH3/P-cadherin expression is associated with aggressiveness of human glioblastoma 2018
- CDH3/P-cadherin as a novel biomarker in glioblastoma: functional and prognostic insights 2018
- WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma 2018
- Functional impact and prognostic relevance of CDH3/P-cadherin in glioblastoma 2018
- WNT6 regulation in Glioblastoma: Mechanistic, Functional and Clinical implications 2017
- CDH3/P-cadherin as a putative HOXA9 target in gliomas: functional and clinical relevance 2017
- Regulation of WNT6 by HOXA9 in glioblastoma: functional and clinical relevance 2016
- A Transcriptomic Signature Mediated by HOXA9 Sustains Human Glioblastoma Aggressiveness and Resistance to Chemotherapy 2015
- HOXA9-mediated activation of the WNT pathway: functional and clinical relevance in glioblastoma 2015
- A Transcriptomic Signature Mediated by HOXA9 Promotes Human Glioblastoma Initiation, Aggressiveness and Resistance to Temozolomide 2015
- HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma 2014
- HOXA9 promotes glioblastoma initiation, aggressiveness and resistance to therapy 2014
- Regulation of Wnt Signaling by HOXA9 in Glioblastoma: Mechanistic and Prognostic Insights 2014
- WNT6 promoter methylation associates with its expression in glioblastoma 2014
- A Transcriptomic Signature Mediated by HOXA9 Sustains Human Glioblastoma Aggressiveness, Resistance to Chemotherapy and Glioma Initiation 2013
- HOXA9 Promotes Glioma Initiation and Sustains Human Glioblastoma Aggressiveness and Resistance to Therapy 2013
- Long Non-Coding RNA HOTAIR is Transcriptionally Activated by HOXA9 and Is Associated with Poor Prognosis in Glioblastoma. 2013
- Regulation of WNT signaling by HOXA9 in glioblastoma: mechanistic, prognostic and therapeutic insights 2013
- Long Non-Coding RNA HOTAIR is Transcriptionally Activated by HOXA9 and Is Associated with Poor Prognosis in Glioblastoma 2013
- Regulation of WNT6 expression by HOXA9 in glioblastoma and prognostic implications 2012